TipRanks on MSN
Crispr Therapeutics rumor highlighted in Betaville blog
A rumor regarding Crispr Therapeutics (CRSP) was highlighted in Ben Harrington’s M&A-focused Betaville blog, contacts tell The Fly. Shares of ...
As of November 27, CRISPR Therapeutics AG (NASDAQ:CRSP) has a moderately positive opinion, with 60% analysts covering it having a Buy or equivalent rating. With a consensus 1-year median price target ...
CRISPR technology, a revolutionary tool in genetic engineering, has empowered Lambert's iGEM team to tackle a significant health issue: Lyme disease, which affects nearly half a million Americans ...
The Lambert High School team, consisting of young genetic engineers led by Sean Lee and Avani Karthik, aimed to address a significant issue: the difficulty in diagnosing Lyme disease during its early ...
20h
Lyme disease often goes undetected when it's most treatable. These teens are working to change that.
Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback